The Effect of Nefopam on Catheter-related Bladder Discomfort
Not Applicable
Completed
- Conditions
- NefopamCatheter-related Bladder Discomfort
- Interventions
- Registration Number
- NCT03130010
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
In the present study, the investigators evaluated whether nefopam 20 mg reduce the catheter-related bladder discomfort in patients undergoing foley catheter insertion
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 110
Inclusion Criteria
- Patients scheduled to insert the catheter a new foley catheter more than 14 Fr in the operation site,
- Adults 20 to 75years of age
- American Society of Anesthesiologists Physical Classification 1,2 patients
- Patients who pre-agreed to the study
- Male patient
Exclusion Criteria
- Neurogenic bladder
- Patients diagnosed with irritable bladder
- study drug sensitive or contraindicated
- Patients with central nervous system or neurological disorder (epilepsy, patients receiving MAO inhibitor)
- Patients with urethral and prostate disorders
- Patients with previous history of myocardial infarction
- Patients with closed angle glaucoma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description The control group Nefopam or saline One hour before the end of the operation, the control group was received 20 ml of saline. The Nefopam group Nefopam or saline One hour before the end of the operation, the Nefopam group was received 20 mg of nefopam.
- Primary Outcome Measures
Name Time Method catheter-related bladder discomfort postoperative 1 hour assessment of catheter-related bladder discomfort using visual analogue scale
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National Univ. Bundang Hospital
🇰🇷Seongnam-si, Gyeonggi-do, Korea, Republic of